JESSICA WONG: Open Payments
NPI 1568003465 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 16 payments from 7 companies in 2025. Trend: 2023 $80 · 2024 $367 · 2025 $473
Food & beverage: $244Education: $229
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $164 |
| Regeneron Healthcare Solutions, Inc. | 2 | $98 |
| UCB, Inc. | 4 | $84 |
| ABBVIE INC. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $16 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, COSENTYX, RINVOQ, NUZYRA, OTEZLA.
Industry payments across FL — which companies pay providers there.
